We provide professional third-party GxP audit services for chemicals, biological products and packaging materials, and help improve the quality system of various pharmaceutical enterprises and pharmaceutical companies. In the audit process, our rich practical experience enables the US to accurately grasp the key points of the audit, in accordance with Chinese GMP, US cGMP, EU GMP and other relevant regulations, and refer to the official inspection characteristics, relevant industry guidelines, and our practical experience of on-site inspection, etc. Maintain effective communication with customers from multiple levels and aspects such as procedural regulations, regulatory requirements, and technical compliance to ensure the rapid progress of the project.
Accumulated services for more than 520+ times, 410+ customers, and third-party GxP audits of multiple APIs, preparations, and biological products, including drug production site, quality system, laboratory, new production plant, and related system document improvement, data integrity improvement, GSP audit, etc., and issued relevant GxP audit reports.
As a subsidiary of Tigermed, we have a strong background and work with Tigermed Group and other sister companies to provide a one-stop service platform for domestic and international clients from R&D, registration, and transformation to production.
Over the last two decades, Canny has formed a mature and standardized service system in terms of the consultant team, service standards, service protocols, project management, and confidentiality system, and has passed ISO 9001 quality management system certification for many years, providing professional services to more than 1370+ Chinese and foreign clients in total.
practices in pharmaceutical industry
Global clients and partners
Global GMP inspection & certification projects
We always have a good communication with authorities, closely follow-up the updated industry trends, and establish a fully-fledged information and documents database, which enable us to have strong information integrating and analyzing capabilities so as to share with our clients and support them from R&D system establishment, clinical trials operation, RA, GMP compliance and MAH related support.